Back to results
US 2026/0166022 A1Published application
Use of glutamate 2b receptor antagonists and sigma receptor agonists as antitussives
AssigneeSeyltx, Inc.
InventorMark Williams
Life of this patent
Estimating the term…
Abstract
The use of glutamate 2b receptor antagonists and sigma receptor agonists as antitussives to treat or prevent a cough is disclosed. In preferred embodiments, the glutamate 2b receptor antagonist is ifenprodil or radiprodil. Preferred sigma receptor agonists include fluvoxamine, fluoxetine, excitalpram, and donepezil.
Claims18
1-20. (canceled)
A method for treating a patient suffering from chronic cough, the method comprising administering to the patient a pharmaceutical composition comprising:
- (i) a therapeutically effective amount of ifenprodil or a salt thereof;
- and
- (ii) one or more pharmaceutically acceptable excipients,
- thereby alleviating one or more cough symptoms in the patient.
1 more element
Dependencies are inferred from the claim text.